1 / 7

Tumour Ablation Market Growing at a CAGR of 8.2% by 2024

The global tumour ablation market has accounted for USD 1.8 billion in 2016, expected to reach USD 3.5 billion by 2024, growing at a CAGR of 8.2% in the forecast period 2017 to 2024.

DataBridge
Download Presentation

Tumour Ablation Market Growing at a CAGR of 8.2% by 2024

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. TumourAblation Market – Global Industry Trends and Forecast to 2024 Global Tumour Ablation Market, By Type (Tumour Ablation Systems (Radio Frequency Ablation, Microwave Ablation, HIFU, Laser Ablation, Cryoablation), Image Guidance Products, Accessories), By Cancer Type (Liver, Lings, Kidney, Brain, Bone, Pancreas, Breast, Others), By End-User (Hospitals, Oncology Clinics, Others), By Geography (North America, South America, Europe, Asia-Pacific, Rest of the World) – Trends and Forecast to 2024 Browse Full Report and Details TOC : http://databridgemarketresearch.com/reports/global-tumour-ablation-market/

  2. Report Description The Global Tumour Ablation Market has accounted for USD 1.8 billion in 2016, expected to reach USD 3.5 billion by 2024, growing at a CAGR of 8.2% in the forecast period 2017 to 2024. The global tumour ablation market is expected to grow, owing to factors such as rising cancer incidence, increased focus on treatment of breast cancer, better reimbursement scenarios, shift towards value based reimbursements and continuous development in ablation technology. The ablation technology has an upper edge on chemotherapy and other oncology therapeutics. Request Sample Report : http://databridgemarketresearch.com/request-a-sample/?dbmr=global-tumour-ablation-market

  3. Market Segmentation The global tumour ablation market is segmented based on product types, cancer types, end-user and geography. The global tumour ablation market is segmented into 3 type’s ablation systems, image guidance products and accessories. The ablation systems dominates the market and is further segmented based on product type into microwave ablation (coretherm thermotherapy devices and prolieve thermotherapy devices), radiofrequency ablation (RFA) ((temperature controlled devices, fluid cooled, catheter manipulation systems), high intensity focused ultrasound (HIFU), laser ablation and cryoablation. All ablation techniques are percutaneous except HIFU which is administered transcutaneously. Request for Customization @ sales@databridgemarketresearch.com

  4. Market Segmentation On the basis of cancer types treated using ablation devices the market is segmented into liver, lings, kidney, brain, bone, pancreas, breast and, other cancer types. In 2015, the liver cancer treatment is the most used application for ablation devices; however in the forecast period market potential for breast cancer is expected to be highest and is going to dominate the market by 2024. Based on end-user the global tumour ablation market is segmented into hospitals, oncology clinics and others. In 2015, hospitals segment dominate the market with more than 65% market share. http://databridgemarketresearch.com/speak-to-analyst/?dbmr=global-tumour-ablation-market

  5. Regional Analysis • Based on geography the market is segmented into 5 geographical regions, • North America • Europe • Asia-Pacific • South America • Rest of the world • The geographical regions are further segmented into 24 major countries such as U.S., Canada, Mexico, Germany, France, U.K., Belgium, Switzerland, Belgium, Turkey, Japan, China, Singapore, Brazil, India, Russia, South Africa and many others. In 2016, Europe is expected to dominate the market with 36.7% market share, owing to the large incidence of cancer patients in this region coupled with good reimbursements.

  6. Major Key Players • Major players in the Global Tumour Ablation Market are: • Galil Medical, Inc. • Perseon Corporation • NeuWaveMedical, Inc. • KoninklijkePhilips N.V. • INTIO Inc. • Mermaid Medical A/S • SonaCareMedical, LLC • DFINE, Inc. • Misonix, Inc. and, HealthTronics, Inc. among other companies. http://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-tumour-ablation-market

  7. About Data Bridge Market Research An absolute way to forecast what future holds is to comprehend the trend today! Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth  the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Read Continue : http://databridgemarketresearch.com/about-us/ Contact Us : Ankit Singh+1-888-387-2818 (Toll Free) sales@databridgemarketresearch.com

More Related